Printer Friendly

THERMO CARDIOSYSTEMS HEART-ASSIST DEVICE TO UNDERGO FDA PANEL REVIEW

 WOBURN, Mass., Nov. 10 /PRNewswire/ -- Thermo Cardiosystems Inc. (AMEX: TCA) announced today that the U.S. Food and Drug Administration's Advisory Panel on Circulatory System Devices plans to review the company's air-driven left ventricular-assist device (LVAD) system when that panel meets on Dec. 13, 1993. The Advisory Panel review is a significant milestone in the company's application for commercial approval. Thermo Cardiosystems' HeartMate(R) LVAD is the first implantable heart-assist device to reach this regulatory milestone.
 The HeartMate LVAD system is currently in investigational use as a bridge to transplantation at 20 federally approved clinical centers in the United States. Over the past eight years, the device has been used in more than 150 patients whose natural hearts are no longer strong enough to function without assistance. The HeartMate LVAD is implanted in the patient's abdominal cavity and attached to the heart. It then takes over the heart's pumping function for patients who are waiting for a donor heart.
 Thermo Cardiosystems Inc. is a leader in research and development of implantable ventricular-assist devices. These devices are designed to perform substantially all or part of the pumping function of the left ventricle of the natural heart for patients suffering from cardiovascular disease. The company's devices are currently intended for investigational use only. Thermo Cardiosystems Inc. is a public subsidiary of Thermedics Inc. (AMEX: TMD) and Thermo Electron Corporation (NYSE: TMO).
 -0- 11/10/93
 /CONTACT: John Hatsopoulos of Thermo Electron, 617-622-1111/
 (TCA TMD TMO)


CO: Thermo Cardiosystems, Inc.; Thermedics Inc.; Thermo Electron ST: Massachusetts IN: MTC SU:

CM-DJ -- NE002 -- 2634 11/10/93 09:35 EST
COPYRIGHT 1993 PR Newswire Association LLC
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 1993 Gale, Cengage Learning. All rights reserved.

Article Details
Printer friendly Cite/link Email Feedback
Publication:PR Newswire
Date:Nov 10, 1993
Words:265
Previous Article:MEDAMICUS ANNOUNCES SIGNING OF INVESTMENT AGREEMENT WITH EMPI
Next Article:METALLURGICAL INDUSTRIES MODIFIES LEASE AGREEMENT
Topics:

Terms of use | Copyright © 2017 Farlex, Inc. | Feedback | For webmasters